Disease-free Survival
12
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies
Long-term Follow-up of Subjects Treated With CAR T Cells
Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.
DataBase for Analysis of Rectal Cancer Oncological Results
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial
Comprehensive Study on the Quality of Life in Cervical Cancer Patients
Jejunoileal vs Gastric GIST in the Era of Imatinib.
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer
An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer
Prognostic Impact of Anatomical Resection Vs. Non-anatomical Resection for HCC